Suzhou Fushilai Pharmaceutical Co. Ltd. Capital Reinvestment Ratio
Suzhou Fushilai Pharmaceutical Co. Ltd. capital reinvestment ratio. Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Capital Reinvestment Ratio of 2.24x as of December 2024, meaning it reinvests 2% of its operating cash flow (CN¥47.07 Million) in capital expenditures (CN¥105.31 Million). See 301258 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Capital reinvestment ratio of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. This chart tracks Suzhou Fushilai Pharmaceutical Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. See financial flexibility index of Suzhou Fushilai Pharmaceutical Co. Ltd. to measure the company's free cash flow as a share of total liabilities.
Suzhou Fushilai Pharmaceutical Co. Ltd. Capital Reinvestment Ratio by Year (2019–2024)
Suzhou Fushilai Pharmaceutical Co. Ltd. capital reinvestment ratio by year from 2019 to 2024. For the full cash flow conversion analysis, see Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.24x | CN¥47.07 Million | CN¥105.31 Million | ▲ +409.4% |
| 2023 | 0.44x | CN¥94.77 Million | CN¥41.62 Million | ▲ +32.5% |
| 2022 | 0.33x | CN¥151.19 Million | CN¥50.11 Million | ▼ -18.0% |
| 2021 | 0.40x | CN¥199.73 Million | CN¥80.75 Million | ▲ +2.7% |
| 2020 | 0.39x | CN¥166.85 Million | CN¥65.69 Million | ▼ -16.4% |
| 2019 | 0.47x | CN¥150.55 Million | CN¥70.93 Million | — |